You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 26, 2011

Interview with Edward Kelly, Edward Madden, and Tiziana Sucharitkul

Focus Reports

This interview of Edward Kelly, Edward Madden, and Tiziana Sucharitkul covers a broad range of topics dealing with the overall intellectual property situation in Thailand, the impact of expected free trade agreements, and Tilleke & Gibbins’ representation of a large number of clients in the pharmaceutical industry.

RELATED INSIGHTS​ 

January 8, 2013
Leading Southeast Asian regional law firm Tilleke & Gibbins has promoted four attorneys to the firm’s partnership, effective January 2013.Coming from across the major practice groups in the firm’s Bangkok office, the new partners include Charunun Sathitsuksomboon and Kobkit Thienpreecha of the firm’s corporate and commercial group, Chusert Supasitthumrong of the dispute resolution department, and Sukontip Jitmongkolthong of the intellectual property team.
October 12, 2012
On November 22, 2012, the Euromoney Legal Media Group will hold its second annual Asia Women in Business Law Awards at the Renaissance Harbour View Hotel in Hong Kong. Again this year, Tilleke & Gibbins stands amongst a leading group of law firms that will be recognized for their commitment to the advancement of women. The firms will be judged on a range of factors, predominately initiatives for gender diversity, innovation, mentoring, talent management, and female leadership within each firm.
September 5, 2012
Starting October 1, 2012, overseas pharmaceutical manufacturers that have never before been recorded in the Drug Product Registry of Thailand will need to be accredited by the Thai Food and Drug Administration (FDA) before marketing authorization can be obtained. Otherwise, the FDA will not allow the business operator to submit an Application for Importation of Drug Product Sample, which is a required document for drug product registration.